DNLI fund manager activity
Denali Therapeutics Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q4 2017 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | Added | 2,589,403 | $42,751,042 | 0.01% | Feb 9, 2026 |
| Polen Capital Management | New | 26,900 | $444,119 | 0.00% | Feb 12, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | Added | 1,631,496 | $23,689,321 | 0.01% | Nov 12, 2025 |